Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety Study of Microlyte DualGuard

NCT: NCT07695688 · NOT_YET_RECRUITING

NCT IDNCT07695688
StatusNOT_YET_RECRUITING
Start Date2026-08-30
Completion2027-08
SponsorImbed Biosciences (INDUSTRY)
First posted
Last updated

Brief Summary

The primary purpose of this research is to evaluate the safety and effectiveness of Microlyte® DualGuard wound dressing in the healing of partial thickness donor site wounds, also known as skin graft donor sites. This research will assess wound healing, the occurrence of infection, allergic reaction, pain, and itching while subjects are in the hospital and after discharge. Subjects will complete clinic visits through 12 weeks. This research will also assess the occurrence of donor site wound infection, pain and itching, and scarring at 12 weeks, assessed by subjects using the Patient and Observer Scar Assessment Scale (POSAS).

Frequently Asked Questions

What is Safety Study of Microlyte DualGuard?

Safety Study of Microlyte DualGuard is a clinical trial registered under NCT07695688. Current status: NOT_YET_RECRUITING.

What is the status of NCT07695688?

The current status of NCT07695688 (Safety Study of Microlyte DualGuard) is: NOT_YET_RECRUITING.

When did Safety Study of Microlyte DualGuard start?

Safety Study of Microlyte DualGuard started on 2026-08-30.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.